ANGO - AngioDynamics raises sales outlook to $313M for FY26 as Med Tech segment accelerates
2025-10-02 10:03:22 ET
More on AngioDynamics
- AngioDynamics, Inc. (ANGO) Q1 2026 Earnings Call Transcript
- AngioDynamics, Inc. 2026 Q1 - Results - Earnings Call Presentation
- AngioDynamics: A MedTech Powerhouse Emerging From Legacy Overhaul
- AngioDynamics projects $305M–$310M FY26 sales as Med Tech drives double-digit growth
- AngioDynamics Non-GAAP EPS of -$0.03 beats by $0.09, revenue of $80.16M beats by $5.9M